TGFBR1 and Chagas disease: A previous study performed by our group showed that GW788388, a potent selective inhibitor of ALK5, administrated in an acute model of Chagas disease significantly decreased parasitemia, and improved cardiac electrical conduction as measured by PR interval in electrocardiography, restored connexin43 expression, increased survival and decreased cardiac fibrosis.